IMMU $250K LOSS NOTICE: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc.; Reminds Investors with Losses Over $250K of Important Deadline – IMMU
NEW YORK, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a lawsuit on behalf of purchasers of the securities of Immunomedics, Inc. (NASDAQ: IMMU) from August 23, 2018 through December 20, 2018, inclusive (the “Class Period”). The firm reminds investors with losses of more than $250,000 of the important February 25, 2019 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws.
To join the Immunomedics class action, go to https://www.rosenlegal.com/cases-1484.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email firstname.lastname@example.org or email@example.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that the FDA cited Immunomedics in August 2018 for a host of violations observed at its Morris Plains, NJ facility. According to the complaint, these violations included the manipulation of bioburden samples, misrepresentation of an integrity test procedure in the batch record, and the backdating of batch records. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 25, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to https://www.rosenlegal.com/cases-1484.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.Phillip Kim, Esq.Zachary Halper, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 34th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827 firstname.lastname@example.org@email@example.com